Strive Announces the Completion of Semler Scientific Acquisition

DALLAS, TX- (GLOBE NEWSIRE)-January 16, 2026-Strive, Inc. (Nasdaq: ASST) ("Strive") today announced the successful completion of the previously announced acquisition of Semler Scientific.

Strive now holds approximately 12,797.9 bitcoin, becoming the #11 largest public corporate holder of bitcoin globally.

Strive also announces the appointment of Avik Roy as Chief Strategy Officer of Strive. Mr. Roy's initial focus will be on Strive's intentions to monetize the operating business from the Semler Scientific subsidiary by expanding its mandate in early disease detection products.

Mr. Roy began his career in science at MIT and trained as a physician at Yale Medical School before joining Bain Capital, where he focused on biotech companies developing breakthrough therapies for underserved diseases. He later served as President and CEO of the National Institute for Health Care Management and worked as an institutional investor at J.P. Morgan, concentrating on biotechnology and healthcare. He also serves as a Senior Fellow at the Bitcoin Policy Institute and is a co-author of The Satoshi Papers, contributing thought leadership at the intersection of Bitcoin and public policy. Mr. Roy was previously an independent board member of Strive and will step down from that position to join the company in a full-time capacity and serve as a board observer for the company.

Eric Semler, former chairman and Executive Chairman of Semler Scientific, has joined as an independent board member of Strive.

Joe Burnett, previously director of Bitcoin Strategy for Semler Scientific, has joined Strive as VP of Bitcoin Strategy.

About Strive

Strive is the first publicly traded asset management Bitcoin treasury company. Strive is focused on increasing Bitcoin per share to outperform Bitcoin over the long run. Strive holds approximately 12,797.9 bitcoins as of January 16, 2025.

Since launching its first ETF in August 2022, Strive Asset Management, LLC, a direct, wholly owned subsidiary of Strive and an SEC-registered investment adviser, has grown to manage over $2 billion in assets.

About Semler Scientific, Inc. (Nasdaq: SMLR)
Semler Scientific, Inc. is the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and is a leader in medical devices and software to combat chronic diseases. In addition, through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc. develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific's flagship product, QuantaFlo, which is patented and cleared by the U.S. Food and Drug Administration (FDA), provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease. Additional information about Semler Scientific can be found at www.semlerscientific.com.